Researchers at The University of Texas MD Anderson Cancer Center have developed an artificial intelligence (AI) model that ...

Heidi Ledford reports for Nature from Seattle, Washington. Just one week after the landmark US approval of a game-changing drug for advanced pancreatic cancer, the same therapy is showing promise ...

Companies are testing dozens of similar drugs in cancers of the pancreas, lung, colon and more. By Rebecca Robbins and Carolyn Y. Johnson The Food and Drug Administration’s approval on Wednesday of a ...

A drug being developed to treat a serious lung disease may also help to slow the aging process, researchers say. In a small clinical study, patients who took rentosertib – developed by Insilico ...

Dr. Teslo is a biotechnology editor at Works in Progress magazine and a nonresident fellow at the Institute for Progress. The day after Christmas in 2019, Annette Harlow received what would be the ...

For some, mRNA seemed like the biotech investment play of yesteryear, but on the heels of Moderna and Merck’s new mRNA cancer treatment, investors are rushing back in. WSJ’s David Wainer explains.

We've rounded up all the currently active codes below and made it easy for you to copy them on whatever device you're using. Just press the copy button, then follow the instructions below to redeem ...

With these new Roll Anime to Fight codes, you should always have just enough cash to get through the next couple of waves with some new anime heroes by your side. Either that, or you'll be able to ...

Grab some of our The Veil codes to increase your odds of surviving the horrors waiting inside the labyrinth. When everything and everyone is out to get you, some free race rerolls might be the key to ...

The Food and Drug Administration on Wednesday approved a groundbreaking new drug for advanced pancreatic cancer, offering U.S. patients a more effective treatment against one of the deadliest types of ...

Tom Bowen is a senior editor who loves adventure games and RPGs. He's been playing video games for several decades now and writing about them professionally for the best part of a decade. Although he ...